We hear all the time that elements of traditional molecular biology reagent portfolios have become increasingly commoditized. Dictionary.com defines commodity as “any bulk good traded in an exchange…”. By that people generally mean that the reagent is not differentiated by anything other than price. One bag of tips or tubes is the same as the next so why pay…

We see it over and over again. Large bio-tools companies are often cited in surveys by market research participants as the suppliers of research products that they don’t even sell. What is this telling us? The cynical might think it means researchers are just clicking on buttons to get to the end of the survey – and we know…